Clincosm LogoSign in Get a demo

GensiniMI: Gensini Score and STEMI Patients Undergoing Primary PCI

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05679843
Collaborator
(none)
1,200
Enrollment
3.9
Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

Gensini score (GS) provides valuable information on severity and prognosis of coronary artery disease (CAD). We aim to evaluate the relationship between the severity of CAD determined by the GS and short and long term of ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    1200 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Characteristics and Prognosis of STEMI Patients Undergoing Primary PCI With Low
    Anticipated Study Start Date :
    Jan 1, 2023
    Anticipated Primary Completion Date :
    Mar 30, 2023
    Anticipated Study Completion Date :
    May 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Composite outcome including all cause death and re myocardial infarction [6 years]

    Secondary Outcome Measures

    1. ST resolution on ECG after primary PCI [1 hour]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Patients with STEMI underwent primary PCI within 24 hours after first symptoms
    Exclusion Criteria:

    Patients with STEMI 24 hours after first symptoms Pregnant patient <18 years old

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Central Hospital, Nancy, France

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Batric POPOVIC, MD,PhD, Central Hospital, Nancy, France
    ClinicalTrials.gov Identifier:
    NCT05679843
    Other Study ID Numbers:
    • CentralGensini
    First Posted:
    Jan 11, 2023
    Last Update Posted:
    Jan 11, 2023
    Last Verified:
    Dec 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Batric POPOVIC, MD,PhD, Central Hospital, Nancy, France
    STEMI, Gensini,
    Additional relevant MeSH terms:
    Myocardial Infarction
    ST Elevation Myocardial Infarction
    Infarction

    Study Results

    No Results Posted as of Jan 11, 2023